Geriatric Nutritional Risk Index Predictive for Overactive Bladder

Medically reviewed by Carmen Pope, BPharm. Last updated on April 7, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, April 7, 2025 -- The Geriatric Nutritional Risk Index (GNRI) is a reliable predictive marker for overactive bladder (OAB) in the elderly, according to a study published online Feb. 10 in Frontiers in Nutrition.

Wei Zheng, from Hangzhou Medical College in China, and colleagues examined the association between GNRI and the prevalence of OAB in a study involving 17,161 elderly individuals from the National Health and Nutrition Examination Survey between 2005 and 2018. Subgroup analyses were used to assess influencing factors, and the predictive utility of GNRI was examined. A mediation analysis was conducted to assess the influence of inflammatory response and cognitive function on the interaction between GNRI and OAB.

The researchers found that GNRI was significantly lower in the OAB group versus the non-OAB group. GNRI significantly predicted OAB in a multifactorial logistic regression analysis. A nonlinear negative correlation was seen between GNRI and the risk for OAB in the elderly. GNRI outperformed serum albumin or body mass index alone in predicting OAB risk in a receiver operating characteristic analysis. The relationship between GNRI and OAB was mediated by inflammatory response, while a relatively weaker influence on the strength of the association between GNRI and OAB was seen for cognitive function.

"From a clinical perspective, GNRI can be incorporated into routine screening to enhance risk stratification and inform personalized treatment strategies, potentially improving outcomes for OAB patients or those at risk of OAB," the authors write

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords